Provided by Tiger Trade Technology Pte. Ltd.

X4 Pharmaceuticals Inc

4.16
+0.11002.72%
Post-market: 4.160.00000.00%19:30 EDT
Volume:390.76K
Turnover:1.62M
Market Cap:412.45M
PE:-3.35
High:4.18
Open:4.05
Low:4.00
Close:4.05
52wk High:4.83
52wk Low:2.80
Shares:99.15M
Float Shares:62.35M
Volume Ratio:0.69
T/O Rate:0.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2404
EPS(LYR):-1.8726
ROE:-113.08%
ROA:-28.15%
PB:2.65
PE(LYR):-2.22

Loading ...

Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Major Issues Report

Current report, item 5.02
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 10, 2020

Major Issues Report

Current report, items 2.02, 7.01, 8.01, and 9.01
Dec 17, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Dec 09, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Dec 03, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 27, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Nov 26, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 14, 2019

Major Issues Report

Current report, items 1.01 and 2.03
Nov 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 18, 2019

Major Issues Report

[Amend] Current report, item 5.02
Oct 04, 2019

Major Issues Report

Current report, item 7.01
Sep 30, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Sep 20, 2019

Major Issues Report

Current report, item 5.02
Aug 27, 2019

Correspondence

[Cover]Correspondence
Aug 22, 2019

Correspondence

[Cover]Correspondence